How Much Did Captivate Bio Raise?
Funding & Key Investors

Captivate Bio has secured a significant strategic investment, adding to its total funding of $154K. The company recently announced a major strategic investment of $154K on December 31, 2024, underscoring its position in the late-stage funding landscape. This latest capital infusion is expected to fuel further development and expansion of its innovative solutions in cell culture and therapeutic technologies.

What is Captivate Bio?

Captivate Bio
ManufacturingChemicals & Related ProductsBusiness Services

Captivate Bio is dedicated to advancing scientific discovery through a focus on science, empowerment, transparency, and teamwork. The company has established a reputation for successfully developing and commercializing leading-edge technologies within stem cell research, cell therapy, regenerative medicine, and clinical research. Their approach emphasizes transparency and a proactive problem-solving ethos, making them a trusted partner for research and therapeutic organizations. Captivate Bio specializes in cGMP cell culture solutions, including clinically-relevant stem cell media and matrices, cell cryopreservation, and cell processing tools. The company is actively expanding its efforts to address challenges highlighted by COVID-19, with a particular focus on establishing US-based cell culture media manufacturing and enhancing supply chain logistics for the research, therapeutic, and healthcare communities at an affordable price.

How much funding has Captivate Bio raised?

Captivate Bio has raised a total of $154K across 1 funding round:

2024

Debt

$154K

Debt (2024): $154K with participation from Rockland Trust

Key Investors in Captivate Bio

Rockland Trust

Rockland Trust is a financial institution that likely provides debt financing and banking services, supporting companies in their growth and operational needs.

What's next for Captivate Bio?

With its recent strategic investment and a strong foundation in stem cell technologies, Captivate Bio is poised for significant growth. The company's focus on expanding US-based manufacturing and improving supply chain logistics indicates a strategic move to bolster domestic capabilities and ensure reliable access to critical cell culture solutions. This capital will likely support scaling production, enhancing research and development efforts, and potentially forging new partnerships within the scientific and healthcare sectors. Captivate Bio's commitment to a transparent and collaborative approach to science positions it to further empower researchers and drive innovation in therapeutic technologies.

See full Captivate Bio company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Hand, Power & Lawn-care ToolsManufacturing
ManufacturingPharmaceuticals
FurnitureManufacturingRetail
Building MaterialsManufacturingDepartment Stores, Shopping Centers & SuperstoresRetailElectronics

Frequently Asked Questions Regarding Captivate Bio Financial Insights

What are the most recent funding rounds that Captivate Bio has completed, and what were the funding rounds?
Captivate Bio has recently completed 1 funding rounds: Debt on Dec 31, 2024.
What is the total amount of funding Captivate Bio has raised to date?
Captivate Bio has raised a total of $154K in funding to date.
How many funding rounds has Captivate Bio completed?
Captivate Bio has completed 1 funding rounds.
How much funding did Captivate Bio raise in its most recent funding round?
Captivate Bio raised $154K in its most recent funding round.
Who are the lead investors in Captivate Bio's latest funding round?
The lead investor in Captivate Bio's latest funding round was Rockland Trust. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Captivate Bio's history?
The largest funding round in Captivate Bio's history was $154K.
See more information about Captivate Bio